Company patents

NEUBORON THERAPY SYSTEM LTD.

NEUBORON THERAPY SYSTEM LTD. exhibits a highly concentrated patent strategy, with 100.0% of its portfolio in Electrotherapy / Radiation Therapy, a surprising focus given the broader medical device landscape. While this core area saw a significant surge in 2025 with 22 patents (a +46.7% YoY increase), the sharp decline to 5 patents so far in 2026 (-77.3% YoY) suggests a potential shift or a highly cyclical innovation pipeline, especially as smaller categories like Healthcare Informatics show a modest resurgence in 2026 with 2 patents after a 100.0% decline in 2024.

Patent Trend by Technology Area

Yearly patent publications since 2023

Product themes

Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.

59 US filings (since 2023) · 4 categories · 4 themes

Patents

Showing 1-10 of 69

Page 1 of 7